The circulating zymogen form of Factor VII activating protease (FSAP) can be activated by histones and nucleosomes in vivo. These cell-death-associated nuclear factors are also actively extruded into the extracellular space by neutrophils through a process called neutrophil extracellular trap (NET) formation (NETosis). NETs are thought to be involved in host defense, inflammation as well as thrombosis. We have investigated the bidirectional interactions of FSAP and NETs. Phorbol ester-mediated NET formation was marginally stimulated by FSAP. Plasma-derived FSAP as well as exogenous FSAP bound to NETs.
Introduction
Neutrophil extracellular traps (NETs) were originally identified as structures secreted by neutrophils as part of their anti-microbial arsenal 1 . The main constituents of NETs are the decondensed DNA backbone and histones 2 and their primary function is to trap and kill bacteria in addition to classical neutrophil mechanisms such as phagocytosis, degranulation to release toxic mixtures of peptides and enzymes as well as secretion of oxygen radicals 3 .
Bacteria possess defensive strategies in that they secrete nucleases that digest NETs 4 , which frees them and allows their spreading in the host organism.
NET formation is a type of cell death accompanied by decondensation of chromatin, breakdown of granular and nuclear membrane and their fusion with the rest of the cytoplasm.
The final step is the disruption of the plasma membrane and release of NETs by a process termed suicidal NETosis 5 . Another form of NET formation can occur, without cell lysis, called vital NETosis 6 . Chromatin decondensation is a consequence of citrullination of histones through activation of peptidyl arginine deiminase 4 (PAD4) 7 . The generation of reactive oxygen species (ROS) by NADPH oxidase-dependent and independent pathways is also important in NETosis 8 . Different inducers of NETosis are likely to activate various pathways to differing degrees. While microorganisms and their products are physiological activators, phorbol esters, calcium ionophores, lipopolysaccharides and cytokines are often used as model activators. NETs are further coated with a variety of other antimicrobial proteins e.g., elastase, myeloperoxidase, cathepsin G, lactoferrin, pentatraxin3, matrix metalloprotease, proteinase 3 and LL37 9 .
One of the main consequences of NETosis, is the promotion of coagulation by providing a secondary network, in addition to fibrin and von Willebrand factor, to promote platelet activation and aggregation 10 . NETs are associated with tissue factor 11 and also bind to various coagulation factors such as FXII, FX, APC, FVIIa and fibrinogen 12 . NET-bound elastase can also inactivate tissue factor pathway inhibitor (TFPI) 13 , although NET formation per se is not dependent on elastase activity 14 . NETs promote hypercoagulability in patients with sepsis since DNA, histones and neutrophil proteases are all involved in regulating the pro-coagulant activity of NETs 15 . NETs can also influence coagulation and inflammation through their cytotoxic effects on cells 16 . Thus, NETs typify the emerging concept that an overactive inflammation promotes thrombosis.
Factor VII activating protease (FSAP) is a circulating serine protease that is involved at many levels in the coagulation and fibrinolysis cascade 17 and together with various cellular mechanisms it has been shown to be involved in thrombosis 17 , stroke 18 and neointima formation 19 . FSAP binds to nucleic acids, histones and nucleosomes that are the major components of NETs 20 . Endotoxemia in mice can release histones which convert pro-FSAP into an active protease 20 . Addition of histones in plasma can activate pro-FSAP which, in turn, degrades histones 20 . Apoptotic cells can also activate pro-FSAP and, in turn, FSAP can release nucleosomes from apoptotic cells 21 . These finding led us to hypothesize that circulating FSAP would interact with NETs, thus influencing their function. We have tested the bidirectional interactions between FSAP and NETs at a physical and functional level and find that FSAP activity is increased by NETs if the histones, therein, are released. The cytotoxicity of histones is potently neutralized by active FSAP through proteolytic degradation.
Material and Methods

Induction of NET formation and immunofluorescence analysis
Blood was collected from healthy donors after informed consent and under approval of the local ethics committee. Neutrophils were isolated using the dextran sulphate method followed by centrifugation over a density gradient media as previously described 22 . Cells were seeded on glass slides in 24-well plates and stimulated with phorbol-12-myristate 13acetate (PMA, 100 nM) and incubated for 3 h at 37°C in serum-free RPMI medium. Purified plasma FSAP was added together with PMA to determine its influence on NET formation. FSAP was purified from human plasma using a monoclonal antibody column, as previously described 23 and is partially in the zymogen form and the active form. In some experiments 50% hirudin-plasma was added to the cells. Cells were washed and fixed with paraformaldehyde (PFA) (4 % wt/vol) and NETs were visualized using an antibody against the DNA-histone complex (mouse monoclonal anti H2A-H2B-DNA complex; clone #PL2-6 24 ) as primary antibody and respective secondary antibody. Alternatively, cells were stained with 4',6-diamidino-2-phenylindole (DAPI). Finally, glass slides were embedded in ProlongGold ® antifade with DAPI (Invitrogen, Olso, Norway) and analyzed by confocal fluorescence microscopy using a Leica TCS SP5 microscope with an HCX PL APO 40× 0.75-1.25 oil immersion objective, and a Confocal microscope Zeiss LSM 510 (Carl Zeiss Germany) 63x magnification, scale bar 20µm. The number of NET-positive cells was determined using ImageJ software as previously described 25 
Pro-FSAP activation in plasma
For these experiments hirudin plasma was used in preference to heparin plasma or citrate plasma since heparin interacts with NETs and the use of citrate plasma would influence the viability of neutrophils. Hirudin plasma (25 μg/ml Lepirudin/ ml fresh human blood) (Bayer, Wuppertal, Germany) was collected from healthy donors and centrifuged at 550 X g for 15 min to collect plasma. For the determination of the pro-FSAP activation, plasma was incubated with or without NETs in the absence or presence of DNaseI (Pulmozyme®, Genentech, San Francisco, CA) and RNase (Sigma Aldrich) for various time points.
Thereafter, supernatants were collected and FSAP-inhibitor complexes were measured as previously described 26 . Histones were analyzed by Western blotting using an antibody to Histone H3 (rabbit monoclonal D1H2 antibody). Nucleosomes were measured by an ELISA kit (Roche Diagnostics, Mannheim, Germany). In this ELISA the capture antibody is directed against histone and the detecting antibody against DNA.
SDS-PAGE and Western blot analysis
Proteins were separated using SDS-PAGE and transferred to a nitrocellulose membrane by standard procedures. After blocking with Tris-buffered saline (50 mM Tris, pH 7.4, 100 mM NaCl, Tween 20 (0.1% wt/vol) (TBST) containing 5 % (wt/vol) dry milk powder, membranes were incubated with the primary antibody in TBST with 2.5 % (wt/vol) dry milk powder. Blots were washed thoroughly and stained with a horseradish peroxidaseconjugated secondary antibody and signals were developed using ECL prime Western Blotting Detection Reagent (Amersham Systems) as recommended by the manufacturer. Signaling Technology, 4409S, concentration 1:500), goat anti-rabbit Alexafluor 647, and cell nuclei (DAPI, Sigma-Aldrich, D9542, concentration 1:500) as described 27 . Images were taken with the TissueFAXS system (TissueGnostics, Vienna, Austria) and a representative example is shown in Figure 3 .
Immunofluorescence analysis of acute coronary thrombi
Histone cytotoxicity on endothelial cells
Human umbilical vein endothelial cells (HUVEC) were isolated using collagenase and cultivated on collagen-coated dishes (5g/ml) with endothelial basal medium (PromoCell, Heidelberg, Germany), containing hydrocortisone (1 g/ml), EGF (10 ng/ml), bFGF (10 ng/ml) and FCS (5% vol/ vol). Cells were treated with histones (mixed histone preparation from Calf Thymus, Roche) at the indicated concentrations in the presence or absence of other test substances. After incubation of 4 h cells were washed extensively, stained with propidium iodine and analyzed by flow cytometry on FACS Calibur (Becton Dickinson, San Jose, CA).
Statistical analysis
All experiments were replicated in 3-5 independent experiments. The data were analyzed using GraphPad Prism 7.02 (GraphPad Software). Differences between the two groups were analyzed by using a one-way or two-way ANOVA followed by Bonferroni posttest. The results are shown as mean + SEM and the significance is indicated as *p<0.05.
Results:
Binding of FSAP to NETs in vitro
For these studies, we have used a model of NETosis based on the activation of neutrophils with PMA which mimics the ROS-dependent activation of NETs by activating NADPH oxidases similar to several microorganisms 28 To test whether FSAP influences formation of NETs, purified FSAP (10 µg/ml) was added together with or without 100 nM PMA from the beginning of the 4h incubation. FSAP itself did not induce formation of NETs, but slightly increased formation of NETs by PMA ( Fig. 2 A, B ). Thus, in line with its known properties, FSAP binding to NETs was observed.
Immunostaining of FSAP in NETs in acute coronary thrombi
We next examined coronary thrombi to understand the in vivo distribution of FSAP.
For this, the staining pattern of FSAP in a panel of acute coronary thrombi, that are particularly rich in NETs 27 , was characterized. As reported 27 , NETs were found in association with cell nuclei of neutrophils as seen by citrullinated histone H3 staining (Fig. 3 ). The merged picture shows colocalization of FSAP, citrullinated H3 and cell nuclei (red, green, blue). There are also regions where nuclei are intact and lack citrullinated H3 DNA or FSAP immunoreactivity, or regions where FSAP immunoreactivity is localized outside of NETs.
We also performed immunohistochemical staining of these thrombi with the same antibodies as used for fluorescence-based analysis above. A similar pattern of staining was observed confirming that the immunofluorescence-staining pattern was reproducible using different methods (data not shown). We conclude that endogenous FSAP co-localizes with NETs in human coronary thrombi in vivo.
Activation of plasma pro-FSAP by NETs
Since pro-FSAP can be activated by histones and nucleosomes 20 we expected an activation of plasma derived pro-FSAP in the presence of NETs. This was investigated using an ELISA assay for FSAP-α2 anti-plasmin complexes that are formed once pro-FSAP is activated in plasma. Contrary to our expectations, the extent of pro-FSAP activation in plasma showed no difference between control and PMA-stimulated neutrophils (Fig. 4A ). Addition of RNase did not alter this pattern of pro-FSAP activation, but the addition of DNaseI, instead, induced a robust increase in pro-FSAP activation in PMA-treated cells but not in control cells ( Fig. 4A ). We hypothesized that this was due to the release of histones from nucleosomes, thus, we performed Western blot analysis of cell supernatants, and observed more histone release in DNaseI treated and PMA-induced cells (Fig. 4B) . A lower MW band indicating degradation of histone H3 in the supernatants was observed and histone H3 bands disappeared in the presence of exogenous FSAP (Fig. 4B ). Immunofluorescence analysis of histone H3 showed that the normal regular nuclear pattern of staining was disrupted in PMA-treated cells and clusters of extracellular histones were evident. DNase treatment led to a reduction of histone staining on the cells/ NETs (Fig. 4C ). Only histones, but not pure DNA, dosedependently increased FSAP-inhibitor complex formation in plasma as has been shown before 26 . Thus, the release of histones from NETs is required for the activation of pro-FSAP.
Interactions of FSAP with nucleosomes
In an earlier study it was reported that FSAP can release nucleosomes from late apoptotic cells 21 thus, we also measured nucleosome-release from neutrophils in the presence of FSAP. PMA treatment of neutrophils led to an increase in the concentration of nucleosomes release from the cells into the supernatants under serum-free conditions (Fig.   5A ). In the additional presence of purified FSAP there was about a 50% decrease in nucleosome release. This pattern was identical in the presence of RNase. In DNaseI-treated cells no nucleosomes were measurable, because the digestion of DNA leads to a loss of DNAhistone complex-epitope that is detected by this ELISA. The pattern of nucleosomes was also mirrored exactly by the measurements of cell-free DNA (data not shown).
One possible explanation for the FSAP-mediated decrease in immunoreactive nucleosomes may be that the activated FSAP digests histones, as observed above (Fig. 4B) and as reported previously 20 . To test this hypothesis, purified nucleosomes isolated from the nucleosome ELISA kit standard were incubated with and without FSAP in the further presence or absence of the protease inhibitor aprotinin and intact nucleosomes were detected by ELISA. FSAP clearly reduced the levels of nucleosomes and this was not the case in the presence of aprotinin (Fig. 5B) . Thus, FSAP promotes the loss of nucleosomes from NETotic cells by degrading histones and does not release nucleosomes from late apoptotic cells as has been previously suggested 21, 29 .
FSAP inhibits the cytotoxic effect of histones on endothelial cells
Extracellular histones are toxic for cells, which can be neutralized by proteases such activated protein C (APC) 30 ; thus we compared the effects of FSAP to APC. FSAP by itself did not induce apoptosis in endothelial cells, however histones treatment led to a strong cytotoxic effect in cells, determined by propidium iodide (PI) staining as a marker of cell death (Fig. 6A ). Preincubation of histones with FSAP reduced this toxicity and this effect was neutralized by aprotinin ( Fig. 6A ). FSAP was more potent compared to APC in reducing cytotoxicity of histones (Fig. 6B) . This difference was also seen at the level of degradation of purified histones by FSAP and APC (Fig. 6C ). Incubation of histones with FSAP led to a complete degradation of histones. Thus, FSAP could reduce the cytotoxicity of histones towards endothelial cells much more effectively than APC.
Discussion
Pro-FSAP zymogen has a unique mechanism of activation into the active enzyme.
Extracellular histones 20 and nucleosomes released from apoptotic cells were shown to activate pro-FSAP 21 . Thus, FSAP may serve as a sensor of cell death or it can be considered to be a circulating damage-associated molecular pattern recognition molecule (DAMP). Although DNA has been shown to activate FSAP under purified conditions 31 , this is not the case in the presence of plasma 26 . Our finding that NETs, which comprise of chromatin DNA-histone complexes, bind to FSAP in vitro and in vivo to coronary thrombi was not surprising. But, the failure of NETs to activate FSAP was unexpected. However, treatment of NETs with DNaseI released histones and enabled a strong activation of pro-FSAP. A similar result has been shown in a recent report, showing that NETs did not have any pro-coagulant effects per se, but when separated into the individual components, both histones and DNA from NETs were active 32 . Thus, histones and DNA neutralize each other with respect to coagulation as well as FSAP activation. The observations in earlier studies, concluding that nucleosomes activate FSAP 21 , may have been due to the presence of free histones in the nucleosome preparations.
A caveat in this study is that PMA was used as an inducer of NETosis. Although widely used as a model inducer it may activate NETosis in a different way compared to microorganisms and bacterial products or cytokines 28 .
DNAses are present in blood 33 and, to a certain extent, any NETs produced in blood would therefore be digested by them 34 . The fact that NETs and NET-associated FSAP is found in thrombi indicates that endogenous DNases are not completely effective in degrading NETs, and that there is probably equilibrium between the formation and dissolution of NETs.
DNase treatment of NETs neutralizes some of the negative effects of NETs in the context of vascular biology; e.g., it reverses the pro-thrombotic effects of NETs 35 , decreases platelet aggregation and increases microvascular perfusion 36 . However, DNase treatment would also release histones, which would have strong toxic effects [37] [38] [39] as well as being prothrombotic 32 .
Activated protein C (APC) was shown to have cytoprotective effects in a baboon model of sepsis through degradation of histones 39 . Comparison of FSAP and APC, showed that FSAP was by far more potent than APC in reducing the cytotoxic effects of histones on endothelial
cells. Although degradation of histones by FSAP has been previously reported 20 , the context of this in NETosis, neutralization of histone toxicity and comparison with APC
are novel findings. Neutrophil elastase is also released during NETosis, and these can also contribute to degradation of histones in order to reduce their cytotoxicity 40 One of the reported functions of FSAP has been its ability to release nucleosomes from late apoptotic cells 29, 42, 43 . This was demonstrated by staining of cells/ nucleosomes with propidium iodide and annexin V as well as by ELISA for nucleosomes. Although the exact significance of this is not known, it was hypothesized that this would be important in regulating inflammation and autoimmunity 42 . We found that NETosis was related to the release of nucleosomes and thus could test the effect of FSAP on nucleosome release in our The prima facie function of NETs is to protect the host against microorganisms.
In this context we did preliminary experiments to determine if FSAP could influence the viability of bacteria but this was not the case (data not shown). The other function of
NETs seems to be to modulate the haemostasis process in microbial infections. The presence of FSAP on NETs in human thrombi raises the possibility that NETs may serve to concentrate FSAP activity at sites of clot formation where FSAP may have other functions over and above histone degradation. Active FSAP might regulate coagulation and fibrinolysis through cleavage of pro-urokinase, FVII and tissue factor pathway inhibitor 44, 45 . It may also regulate inflammation through cleavage of kininogen as well as generation of anaphylatoxins C5a and C3a 26, 45 and activate protease-activated receptors 46 . Because the balance between NET burden and endogenous DNase activity is one factor determining outcome in vascular thrombosis 27 , FSAP-NET colocalization may be illustrating the NETs-DNAse interaction, and mirror-image the degree of histone neutralization. Carriers of the Marburg I single nucleotide polymorphism of FSAP, which have very low enzymatic activity 47 , would fail to neutralize histones resulting in increased disease susceptibility.
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